Literature DB >> 2962582

Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells.

L C Murphy1, L J Murphy, R P Shiu.   

Abstract

Incubation of T-47D human breast cancer cells with the synthetic progestin, medroxyprogesterone acetate (MPA), resulted in a time and dose-dependent increase in epidermal growth factor-receptor (EGF-R) mRNA. Concentrations of MPA as low as 1 nM resulted in a greater than five fold increase in EGF-R mRNA. A significant increase (2-3 fold) in EGF-R mRNA was apparent 12 hr after exposure to MPA and a further increase was seen 12-48 hr after addition of MPA to the cultures. From these studies it is concluded that the increased EGF binding in progestin-treated T-47D cells results at least in part from increased EGF-R gene expression. We believe this is the first report of a steroid hormone modulating expression of this growth factor receptor gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2962582     DOI: 10.1016/0006-291x(88)90504-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.

Authors:  N P Bates; H C Hurst
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.

Authors:  Christy R Hagan; Tarah M Regan; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

3.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

4.  Epidermal growth factor receptor in adenocarcinoma of the kidney.

Authors:  K E Ambs; A Takahashi; F Hering; S Costa; P R Huber
Journal:  Urol Res       Date:  1989

5.  Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.

Authors:  R D Christen; D K Hom; D C Porter; P A Andrews; C L MacLeod; L Hafstrom; S B Howell
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 6.  Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.

Authors:  M De Bortoli; C Dati
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

Review 7.  EGF receptor expression, regulation, and function in breast cancer.

Authors:  S A Chrysogelos; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

Review 8.  William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms.

Authors:  G Freiss; C Prébois; F Vignon
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.